IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Pivotal bioVenture Partners Investment Advisor LLC

Q1 2022 Holdings

Filed 2022-05-13 | 11 holdings | $11.2M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Arcutis Biotherapeutics Inc(ARQT)COM03969K108$11.0M569,04198.2%
Karuna Therapeutics IncCOM48576A100$108.1K852,7081.0%
Vaxcyte Inc(PCVX)COM92243G108$26.8K1,111,4850.2%
Rallybio CorpCOM75120L100$15.9K2,271,3110.1%
Fusion Pharmaceuticals IncCOM36118A100$12.4K1,598,3770.1%
Exscientia PLCADS30223G102$11.1K772,2850.1%
Akouos IncCOM00973J101$8.5K1,794,0880.1%
Inozyme Pharma IncCOM45790W108$6.5K1,591,1540.1%
Bolt Biotherapeutics Inc(BOLT1EUR)COM097702104$5.2K1,891,4670.0%
Vigil Neuroscience Inc(VIGL)COM92673K108$3.9K560,5950.0%
Aligos Therapeutics IncCOM01626L105$1.9K876,5480.0%